1. Introduction {#sec0005}
===============

Aluminum phosphide (AlP) has been extensively used on account of its ideal properties like leaving little residue on food grains and exterminating insects with no impact on seed viability \[[@bib0005]\]. However, its widespread use has contributed to a marked increase in the related suicidal \[[@bib0010]\] and accidental poisonings \[[@bib0015]\] with high-risk mortality \[[@bib0020]\]. Due to unlimited and uncontrolled accessibility, AlP poisoning is one of the most common causes of poisoning in the developing countries such as India \[[@bib0025], [@bib0030], [@bib0035], [@bib0040]\] and Iran \[[@bib0045], [@bib0050], [@bib0055], [@bib0060], [@bib0065], [@bib0070], [@bib0075]\]. AlP-poisoned cases have been also reported from developed countries \[[@bib0080]\].

Following AlP ingestion, reaction with hydrochloric acid in the stomach produces a lethal gas called "phosphine" (PH~3~) ([Fig. 1](#fig0005){ref-type="fig"}). Interestingly, prompt liberation of this gas following exposure to atmospheric moisture, has also made AlP a potential chemical terrorism agent \[[@bib0085]\]. Phosphine induces cellular hypoxia by affecting the mitochondria \[[@bib0090]\], inhibits cytochrome c oxidase \[[@bib0095]\] and leads to formation of highly reactive hydroxyl radicals \[[@bib0100]\]. The signs and symptoms of AlP intoxication are nonspecific and appear instantaneously \[[@bib0105]\]. AlP-related fatality is attributed to cardiac failure caused by inhibition of cytochrome c oxidase, decrement of adenosine triphosphate (ATP) production and cardiomyocyte impairment \[[@bib0110]\]. Oxidative stress has been shown to play a major role in AlP toxicity \[[@bib0115]\]. Nevertheless, AlP-induced inhibition of cytochrome c oxidase as the underlying cause of AlP toxicity, has raised controversies \[[@bib0120]\]. No definitive antidote has been proven clinically efficient \[[@bib0125]\]. AlP toxicity is mainly treated by supportive approaches \[[@bib0130]\] including intra-aortic balloon pump \[[@bib0135]\] and extracorporeal membrane oxygenation (ECMO), a recent promising technique that provides temporary cardiorespiratory support \[[@bib0140], [@bib0145], [@bib0150]\]. Here, we discuss the pros and cons of different agents suggested as potential antidotes for AlP.Fig. 1Pathophysiology of aluminum phosphide (AlP) intoxication. After ingestion, AlP reacts with stomach acid and releases phosphine (PH~3~) gas. PH~3~ reaches the heart through the systemic circulation and causes myocardial cell death and arrhythmias.Fig. 1

2. Mechanisms of AlP-related toxicity {#sec0010}
=====================================

Subsequent to ingestion and upon contacting water/acid in the gastrointestinal (GI) tract, AlP produces PH~3~ which is then absorbed. Absorption through the skin and eyes has not been frequently reported, but may take place. Since phosphine is a small molecule, it is distributed all over the body. Intact AlP is excreted in the urine. Hypophosphite is the major urine metabolite of PH~3~ while exhalation is the removing pathway for pure PH~3~ \[[@bib0155]\].

By inhibiting the production of cell enzymes and proteins, PH~3~ causes toxicities similar to that induced by metal phosphides \[[@bib0095]\]. Non-competitive blockade of cytochrome c oxidase leads to the inhibition of oxidative phosphorylation and cellular respiration and consequently, overproduction of peroxide radicals. Cell membrane dysfunction also happens due to catalase inhibition and glutathione reduction \[[@bib0160]\]. PH~3~ inhibits cytochrome c oxidase in the cardiac cell as it negatively affects mitochondria and myocardial proteins. These effects are mediated through impairment of cellular permeability to major ions and alterations in the cardiac cell wall potential \[[@bib0120]\]. Increases in Heinz bodies (*i.e.* denatured hemoglobin) and hemichrome formation are also observed following PH~3~ reaction with hemoglobin, consequently reducing heme capacity \[[@bib0165]\]. As evidenced by post-mortem histopathological studies, organs such as the heart, lung, kidney, and liver with higher oxygen demands, are more sensitive to PH~3~-induced damage involving oxygen free-radicals production \[[@bib0170]\]. In a 70-kg individual, 500 mg AlP has been reported as the lethal dose. Moreover, 400--600 mg/L phosphine level in the air may lead to death after 30 min \[[@bib0155]\].

3. Approach used in this review {#sec0015}
===============================

Scientific databases such as PubMed, Scopus and Web of Science were searched for the following terms: 'aluminum phosphide', 'phosphine', 'antidote' and 'protective role', from January 1980 up to May 2018. We reviewed the abstracts of relevant articles, looking particularly for those examining special antidotes against AlP. Duplicate articles or articles that did not match our subject, were excluded. Experimental (including *in vitro* and *in vivo*) and human studies were presented separately.

4. Magnesium sulfate {#sec0020}
====================

4.1. Human studies {#sec0025}
------------------

Contradictory results have been reported concerning the utilization of magnesium sulfate as therapeutic agent in AlP-intoxicated patients. Based on some studies, AlP intoxication did not induce hypomagnesaemia and magnesium sulfate therapy did not improve the patient conditions \[[@bib0175],[@bib0180]\]. By contrast, other investigations showed that magnesium level decreased in AlP poisoning, thus supporting the hypothesis that improving magnesium level can be regarded as a step towards treatment of AlP poisoning \[[@bib0185]\]. Consistent with this hypothesis, it was suggested that hypomagnesaemia might be the major cause of high mortality in AlP-intoxicated patients and its rectification is lifesaving \[[@bib0190]\].

The anti-peroxidant effects of magnesium were evaluated in fifty AlP-poisoned patients \[[@bib0195]\]. After demonstrating that AlP-induced oxidative stress in the early phase of poisoning was responsible for increase in lipid peroxidation and reduction in glutathione (GSH) levels, the authors reported significant improvement in patients receiving magnesium. They explained that AlP-induced oxidative stress was able to induce transient fall in magnesium and magnesium-dependent GSH, leading to increased susceptibility towards oxygen free radical-induced damages and resulting in elevated levels of lipid peroxidation.

5. Melatonin {#sec0030}
============

Melatonin may specifically ameliorate AlP-induced cardiotoxicity. Primarily, its amphiphilic structure allows its penetration into the intracellular compartments such as mitochondria. As it scavenges reactive oxygen species (ROS), melatonin is also known as robust antioxidant. Additionally, melatonin not only extenuates the suppression of respiratory chain complexes but also intensifies ATP production. It prevents apoptosis by restraining the mitochondrial permeability transition pore and disturbing caspase activation after inhibiting cytochrome c release \[[@bib0200]\]. Therefore, melatonin administration was suggested as a potentially beneficial approach against AlP-induced cardiotoxicity.

6. *In vitro* and *in vivo* studies {#sec0035}
===================================

Several *in vitro* investigations suggested that melatonin can overcome AlP-induced oxidative damage; however, further researches are still warranted to evaluate the feasibility of using melatonin as antidote to treat AlP-poisoned patients. Interestingly, PH~3~ was shown to increase lipid peroxidation (as reflected by the levels of malondialdehyde (MDA) and 4-hydroxyalkenals (4-HDA)) in a concentration (0.25--2 m[M]{.smallcaps})- and time (30--150 min)-dependent manner, with the maximum level of 2.9‐fold increment achieved at 90 min at the concentration of 1 m[M]{.smallcaps} PH~3~, in brain homogenates \[[@bib0160]\]. Similarly, PH~3~ (4 mg/kg, intraperitoneally (IP)) induced brain DNA oxidation \[as reflected by the levels of 8-hydroxyguanosine (8-OH-dG)\] *in vitro* and in the frontal cortex and lowered brain glutathione peroxidase activity *in vivo*. Melatonin (0.1--2 mM) dose-dependently restored all PH~3~-induced consequences in the brain, probably through its free-radical scavenging ability

6.1. Animal studies {#sec0040}
-------------------

PH~3~ (4 mg/kg, IP) was shown to significantly decrease GSH, GSH peroxidase and catalase, 30 min after its administration to male Wistar rats \[[@bib0160]\]. By contrast, PH~3~ raised the levels of lipid peroxidation, DNA oxidation and superoxide dismutase (SOD) activity, in the kidney and heart. All these changes were reversed by melatonin 10 mg/kg, administered IP 30 min before injecting PH~3~) in cardiac tissues, with the exception of SOD activity.

To estimate melatonin-attributed effects on 16.7 mg/kg AlP-induced decline in heart rate and blood pressure, several doses of melatonin (20, 30, 40 and 50 mg/kg; IP) were administered \[[@bib0205]\]. Significant improvements were observed in the activities of mitochondrial complexes, oxidative stress biomarkers and ADP/ATP ratio following 40 and 50 mg/kg melatonin administration.

In another Wistar rat study, PH~3~ was shown to significantly decrease GSH concentration and elevate lipid peroxidation in the brain, lungs and liver 30 min after the administration of PH~3~ (2 mg/kg, IP) \[[@bib0210]\]. The preventive effects of melatonin (10 mg/kg), vitamin C (30 mg/kg) and β-carotene (6 mg/kg) injected IP 30 min before PH~3~ administration were thereafter examined. Only melatonin was able to block PH~3~-induced changes, while vitamin C and β-carotene were not effective.

7. Coconut oil {#sec0045}
==============

7.1. Human studies {#sec0050}
------------------

In a 28-year-old man, coconut oil administered six hours after the ingestion of a lethal amount of AlP (12 g) was shown to reduce the expected amount of absorbed AlP \[[@bib0215]\]. Thereafter, coconut oil was suggested as a possibly lifesaving and useful antidote for AlP poisoning. In another report, thirty-three AlP-intoxicated patients admitted to the intensive care unit received extensive gastric lavage using a mixture of coconut oil and sodium bicarbonate \[[@bib0180]\]. The mean length of hospital stay was 5.84 ± 1.86 days and the survival rate was 42%. Based on these findings, the authors claimed that coconut oil was effective in increasing the survival rate. Seven AlP-poisoned patients with severe hemodynamic conditions treated with supportive measures also received gastric lavage with diluted potassium permanganate, coconut oil and sodium bicarbonate \[[@bib0130]\]. Since 4 out of the 7 patients survived, the authors similarly proposed that coconut oil may be regarded as an efficient therapy as long as no specific antidote exists. Nevertheless, the absence of a control group (*i.e.* intoxicated patients who were not treated with coconut oil), could be regarded as a limitation and should be considered when interpreting the findings.

8. *N*-acetylcysteine (NAC) {#sec0055}
===========================

8.1. Animal studies {#sec0060}
-------------------

The effects of NAC on acute and chronic toxicities of AlP (10, 20, 40 mg/kg, IP) were studied in the heart, lung, kidney and liver of white male mice \[[@bib0220]\]. Besides delaying the latency to death, NAC (50--100 mg/kg, IP) prevented hepatic necrosis. Interestingly, significant delay in latency to death was also observed following the administration of vitamin C (500--1000 mg/kg, IP) in this study.

The protective effects of NAC and N omega-Nitro-L-arginine methyl ester (L-NAME) against AlP (12.5 mg/kg) administered by intragastric route were investigated in the rat \[[@bib0225]\]. It was recorded that AlP deteriorated the hemodynamic profile and biochemical parameters leading to the rat death with a mean survival time of 90 ± 10 min. After NAC infusion (6.25 mg/kg/min, intravenous (IV) for 30 min), the parameters of AlP-poisoned rats were significantly improved, while treatment with L-NAME (1 mg/kg/min, IV for 60 min) neither improved the survival time nor the biochemical parameters although it significantly raised blood pressure. Co-administration of NAC and L-NAME to AlP-poisoned animals worsened the survival time as compared to untreated AlP-poisoned rats. Based on these findings, the authors concluded that NAC, in contrast to L-NAME, reduces AlP-induced myocardial oxidative damage and increases survival time. In both mouse and rat models, NAC could successfully increase the survival time.

8.2. Human studies {#sec0065}
------------------

Studies are controversial \[[@bib0230]\]. Several case reports like the one reporting a 20-year-old female intoxicated with both AlP and zinc phosphide, who survived after intensive treatment with NAC, digoxin and insulin \[[@bib0235]\], have been used to claim the beneficial effects of NAC in AlP-poisoned patients.

In a 2013 prospective, randomized, controlled open-label trial recruiting thirty-seven AlP-intoxicated patients (22 treated with NAC and 15 serving as controls), NAC significantly reduced the plasma MDA level (139 ± 28.2 μmol/L in the NAC-treated patients *vs.* 149.6 ± 35.2 μmol/L in the controls; *p* = 0.03), duration of hospitalization (2.7 ± 1.8 *vs*. 8.5 ± 8.2 days; *p* =  0.02), mechanical ventilation (45.4 *vs*. 73.3%; *p* =  0.04) and mortality rate (36 *vs*. 60% with odds ratio of 2.6 (95%-confidence interval, 0.7--10.1), confirming NAC-attributed benefits in AlP poisoning \[[@bib0240]\]. Though statistically significant differences were found in MDA levels following treatment with NAC, authors did not discuss the clinical significance of this alteration.

A second study, carried out in an emergency medical unit in India, investigated the antioxidant effects of NAC on mortality in 50 severely AlP-poisoned patients over a period of one year \[[@bib0245]\]. NAC was given IV in 5% dextrose, with a loading dose of 150 mg/kg over one hour, followed by 50 mg/kg over four hours and 100 mg/kg over 16 h. The mortality rate was 87.5% in the treatment group *versus* 88.5% in the placebo group. Survivors in the treatment group received 19 g NAC and non-survivors received only 12.15 g NAC. In this study, NAC did not improve the outcome of severe AlP poisoning.

In a case-control study, addition of NAC (300 mg/kg, infused IV for 20 h) to the routine treatment was shown to be beneficial on AlP-attributed cardiac alterations (creatine kinase MB, creatine phosphokinase, heart rate, and mean systolic blood pressure) in 46 patients (23 patients in the NAC group and 23 controls) \[[@bib0250]\]. NAC prevented sharp heart rate fluctuations. Creatine phosphokinase levels were significantly different 24 h after admission in both groups (one group received intravenous NAC plus conventional treatment while the other group did not receive NAC) in comparison to those measured before treatment (*p* \< 0.001). In a cohort study, oxidative stress was evaluated in patients who received NAC along with supportive treatment \[[@bib0255]\]. The baseline catalase (p = 0.008) and SOD levels (*p* \<  0.01) were significantly higher among survivors (32.6% of the patients) than non-survivors (67.4% of the patients), suggesting NAC ability to recuperate survival by ameliorating oxidative stress in AlP-poisoned patients.

9. Sodium selenite {#sec0070}
==================

9.1. Animal study {#sec0075}
-----------------

Pretreatment with sodium selenite in male albino mice intoxicated by AlP (10, 20 and 40 mg/kg, IP) was shown to reduce pulmonary and liver complications (as evidenced by edema and fatty changes), though it had no effects on mortality latency occurring 35 ± 15 min after AlP administration \[[@bib0220]\].

10. Vitamin E {#sec0080}
=============

10.1. Human studies {#sec0085}
-------------------

Vitamin E has recently been mentioned as a useful treatment for AlP poisoned patients. A 21-year-old male who ingested a 3-g AlP tablet, was successfully treated with a combination of routine approaches and administration of antioxidants such as vitamin C (1000 mg every 12 h *via* slow IV infusion), vitamin E (400 Units, IM) and NAC (140 mg/kg oral as a loading dose followed by 70 mg/kg oral every 4 h, for up to 17 doses) \[[@bib0260]\]. Administered at 400 mg BD by intramuscular (IM) route besides other supportive treatments to AlP-poisoned subjects, vitamin E was able to decrease the requirement (30 *vs*. 62%) and duration of mechanical ventilation and reduce the mortality rate (15% *vs*. 50%), as compared to controls \[[@bib0265]\].

11. Triiodothyronine {#sec0090}
====================

11.1. Animal study {#sec0095}
------------------

The cardio-protective effect of triiodothyronine (T3) (1, 2 and 3 μg/kg, IP 30 min after 12 mg/kg AlP administration) was observed in rats \[[@bib0270]\]. In this study, T3 3 μg/kg significantly improved cardiovascular features (including decrement of heart rate, blood pressure and abnormal QRS complexes, QTc and ST height on the ECG) as well as oxidative stress indices. T3 ameliorated mitochondrial function and ATP levels in the cardiac cells while decreased apoptosis by diminishing caspase 3 and 9 activities and enhancing cell viability. The experimental findings highly suggested beneficial effects of T3 against AlP-induced cardiotoxicity in rats.

12. Liothyronine {#sec0100}
================

12.1. Human study {#sec0105}
-----------------

After gastric lavage, liothyronine (50 μg) was administered to twelve AlP-intoxicated patients *via* a nasogastric tube \[[@bib0275]\]. Oral liothyronine significantly ameliorated systolic blood pressure, arterial pH, and total thiol molecules while reducing lipid peroxidation, elevating catalase activity, and maintaining total antioxidant capacity. Altogether, liothyronine was suggested to be a promising adjuvant therapy in AlP-poisoned patients.

13. Vasopressin and milrinone {#sec0110}
=============================

13.1. Animal study {#sec0115}
------------------

The protective effects of vasopressin (2.0 IU/kg, IP) and milrinone (0.25 mg/kg) on cardiovascular function, oxidative stress and apoptosis, were investigated in rats poisoned with AlP (12.5 mg/kg, by gavage) \[[@bib0270]\]. Vasopressin and milrinone not only had short-term cardio-protective effects but also reconstructed mitochondrial function, improved ATP level and reduced the oxidative damage in long-term which protected cardiomyocytes against apoptosis.

14. *Laurus nobilis* L {#sec0120}
======================

14.1. *In vitro* study {#sec0125}
----------------------

The defensive effects of the leaf extract of *Laurus nobilis* L. (LNE), a plant with antioxidant and antibacterial properties, against AlP-induced genotoxicity and oxidative damages were investigated in cultured human blood cells \[[@bib0280]\]. Co-application of LNE (25, 50, 100 and 200 mg/l) and AlP (58 mg/l) decreased the total oxidative levels but increased the total antioxidant capacity (TAC) as compared to the controls. The preventive role of LNE in moderating AlP-induced DNA-damage was pointed out, as sister chromatid exchange and chromosome aberration were also decreased in AlP-exposed rats treated with LNE in comparison to the controls.

14.2. Animal study {#sec0130}
------------------

The protective effects of LNE (200 mg/kg for 14 successive days, IP) against AlP toxicity were investigated in the rat \[[@bib0285]\]. LNE was shown to suppress the genetic damage and oxidative stress caused by AlP. The protective effect of LNE was attributed to its antioxidant and free-radical scavenging features.

15. 6-aminonicotinamide (6-AN) {#sec0135}
==============================

15.1. *In vitro* study {#sec0140}
----------------------

AlP-poisoned patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency were reported to survive surprisingly \[[@bib0290],[@bib0295]\]. Therefore, to investigate the probable effects of G6PD deficiency in protecting the patients against AlP toxicity, isolated hepatocytes were treated with 6-aminonicotinamide (6-AN; 3 μg/ml for 2 h) as an inhibitor of the NADP^+^-dependent 6-phosphogluconate dehydrogenase \[[@bib0300]\]. All analyzed parameters such as cell viability, ROS formation, mitochondria membrane potential (MMP), lysosomal integrity, reduced GSH content, and lipid peroxidation significantly decreased in hepatocytes pretreated with 6-AN for 10 min compared to the controls, providing evidence on the protective role of G6PD deficiency which could be induced by 6-AN.

15.2. Boric acid {#sec0145}
----------------

Boric acid, a non-toxic Lewis acid, may act as a "trapping agent" for phosphine which is a Lewis base, leading to phosphine excretion in the urine. Thus, boric acid appears as a potential antidote for AlP poisoning \[[@bib0305]\].

15.3. *In vitro* Study {#sec0150}
----------------------

One-gram AlP tablets were added to 200 ml of various solvents including distilled water, activated charcoal diluted in distilled water and saturated boric acid solution \[[@bib0310]\]. Each solution was used at both normal and acidified pH and separately examined. The volume of released gas and the rate of gas evolution throughout reactions of AlP tablets were compared among the various groups. Although boric acid did not significantly decrease the amount of released gas, it significantly reduced the grade of gas evolution. A gaseous adduct was created in the reaction between AlP and boric acid. These findings showed possible benefits of boric acid in treatment of PH~3~ poisoning.

16. Acetyl-L-carnitine {#sec0155}
======================

16.1. Animal study {#sec0160}
------------------

Effects of acetyl-L-carnitine (ALCAR; 100, 200, and 300 mg/kg, IP) on AlP-induced toxicity were investigated in a rodent model with regard to mitochondrial respiratory chain activity, ATP production, oxidative stress and cellular apoptosis/necrosis \[[@bib0315]\]. ALCAR significantly ameliorated oxidative stress (*i.e.* reduced elevated ROS and plasma iron levels) and elevated the activity of cytochrome oxidase which in turn amplified ATP production. Moreover, flow cytometric assays used to report apoptotic/necrotic cells percentages and evaluate caspase-3 and caspase-9 activities, showed that ALCAR prevented AlP-induced apoptosis in cardiomyocytes.

A detailed summary of the novel modalities investigated for treatment of AlP poisoning, is given in [Table 1](#tbl0005){ref-type="table"}.Table 1Antidotes studied for treatment of AlP intoxication.Table 1TreatmentExperimental modelDose/route of AlPDose/routeMain findingsMagnesium sulfateHuman study----Improved oxidative stress statusMelatonin*In vitro* (Rat brain homogenate)0.25-2 mM0.1-2mMAntioxidant activity\
Increased ATP production\
Prevention of apoptosisAnimal study (Rats)4 mg/kg IP10 mg/kg IPAnimal study (Rats)16.7 mg/kg40-50 mg/kg IPAnimal study (Rats)2 mg/kg10 mg/kg IPCoconut oilHuman study12 gOralIncreased survival rateN-acetyl cysteineAnimal study (Mice)10-20-40 mg/kg IP50-100 mg/kg IPDelaying the latency of death\
Prevention of hepatic necrosisAnimal study (Rats)12.5 mg/kg6.25 mg/kg/min Infusion for 30 minImprovement of hemodynamic profile and biochemical parametersHuman study--140 mg/kg infusion (loading dose)\
Followed by 70 mg/kg/IV infusion every 4 hReduction of the duration of hospitalization and mechanical ventilation\
Decrement of mortality rateCase report--300 mg/kg infusion for 20 hImprovement of cardiac alterationSodium seleniteAnimal study (Mice)10-20-40 mg/kg IP3 mg/kgReduction of pulmonary and liver complicationsVitamin ECase report3 g400 units IMDecrement of mechanical ventilation duration\
Reduction of the mortalityTriiodothyronineAnimal study (Rats)12 mg/kg3 μg/kgImprovement of cardiovascular complications\
Decrement of oxidative stress\
Increment of ATP levels\
Decrement of apoptosis rateLiothyronineHuman study50 μg oralAmelioration of cardiac complications and oxidative stressVasopressinAnimal study (Rats)12.5 mg/kg gavage2 IU/kg IPCardio protective effects\
Increment of ATP\
Decrement of oxidative damage and apoptosisMilrinoneAnimal study (Rats)12.5 mg/kg gavage0.25 mg/kg*Laurus nobilisIn vitro* (Cultured human blood cells)58 mg/l25, 50, 100 and 200 mg/lDecrement of oxidative stress\
Decrement of DNA damageAnimal study (Rats)--200 mg/kg for 14 days, IPSuppression of genetic damage\
Decrement of oxidative stress6-aminonicothinamide*In vitro* (Isolated rat hepatocyte)--3 μg/ml for 2 hDecrement of ROS formation and lipid peroxidation\
Increment of cell viabilityBoric acid*In vitro* (Distilled water, activated charcoal, and Saturated boric acid solution)1 g/200 mlSaturated boric acid solutionDecrement of the grade of gas evolutionAcetyl-l-carnitineAnimal study (Rats)--100, 200, 300 mg/kg, IPIncrement of cytochrome oxidase and ATP production\
Decrement of oxidative stress\
Decrement of apoptosis[^1]

17. Discussion {#sec0165}
==============

Several experimental and clinical investigations have suggested some interest to various substances, able to counteract AlP-related toxicity and thus improve the prognosis of AlP-poisoned patients. However, physicians should be cautious. The level of evidence is still very low. Recommendations for utilization of all these antidotes to treat AlP-poisoned patients require further assessments.

Magnesium sulfate did not ameliorate the mortality rate in AlP-intoxicated patients \[[@bib0175]\]. The only obvious outcome following administration of magnesium sulfate was the modification of oxidative stress parameters \[[@bib0195]\]. Similar to magnesium sulfate, sodium selenite did not affect the mortality latency, but seemed able to attenuate pulmonary and hepatic complications \[[@bib0220]\]. Melatonin showed interesting antioxidant activities and improved mitochondrial complex activities, and ADP/ATP ratio \[[@bib0200]\]. Since the effects of melatonin on mortality rate have not been mentioned, more thorough assessments in this regard should be done. Coconut oil covers the stomach and decreases AlP absorption rate and may be used as a potent protective agent against AlP toxicity. Several case series suggested that coconut oil is able to improve AlP poisoning outcome \[[@bib0180],[@bib0215]\]. As an adjutant therapy, NAC may combat AlP-induced cardiotoxicity, prevent liver necrosis, and ameliorate hemodynamic conditions and biochemical parameters. Even at high doses, NAC was well-tolerated without causing side effects and actually reduced AlP-induced mortality rate \[[@bib0250]\]. Vitamin E decreased the fatality rate \[[@bib0265]\] and exerted more marked effects when co-administered with NAC \[[@bib0260]\]. T3 \[[@bib0270]\], vasopressin \[[@bib0270]\] and ALCAR \[[@bib0315]\] were suggested to improve AlP-related alterations in cardiovascular function, ATP levels and apoptosis. Based on *in vitro* studies, 6-aminonicotinamide showed protective activity in hepatocytes \[[@bib0300]\]. Finally, although not fully investigated, boric acid theoretically seems to be a potential antidote by trapping PH~3~ \[[@bib0305],[@bib0310]\].

18. Conclusion {#sec0170}
==============

Oxidative stress and ROS production, as well as inflammatory signaling, mediate the mechanisms of AlP-related toxicity in the poisoned patient. Therefore, using an antioxidant may theoretically be beneficial to limit the toxicity as lifesaving antidote. Various antioxidants have been investigated with considerable efforts; but discrepancies exist among the findings. More in-depth researches are still required to assess the current candidates and find out the most efficacious one able to reduce AlP-induced mortality.
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[^1]: IV: intravenous, IM: intramuscular and IP: intraperitoneal.
